Reza Bayat Mokhtari | Molecular Biology | Editorial Board Member

Published on by Medical Lab Scientist

Dr. Reza Bayat Mokhtari | Molecular Biology | Editorial Board Member

Director | Association of Clinical Immunology and Cancer Research | United States

Dr. Reza Bayat Mokhtari is a research-intensive biomedical scientist recognized for significant contributions to oncology and translational medicine, with a documented impact of 4,475 citations, an h-index of 20, and an i10-index of 30. The research portfolio focuses on molecular mechanisms of cancer progression, tumor microenvironment dynamics, and resistance to therapy, particularly in lung, breast, pancreatic, hepatic, and neuroendocrine malignancies. Core scientific contributions include studies on Hippo–YAP/TAZ signaling, Agrin-driven oncogenic processes, cancer stem cell regulation, hypoxia-associated pathways, and rational combination and repurposing strategies to improve immunotherapy outcomes. This body of peer-reviewed work bridges fundamental cancer biology with clinically relevant translational models, supporting biomarker development and precision oncology approaches. Overall, the scholarly output reflects sustained productivity, interdisciplinary scope, and measurable influence within the cancer research community.

Citation Metrics (Google Scholar)

6000

4500

3000

1500

0

 

4475
Citations

20
h-index

30
i10-index

Citations

h-index

i10-index

Featured Publications

Heming Li | Molecular Biology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Heming Li | Molecular Biology | Research Excellence Award

Doctor | The first hospital of China Medical University | China

Dr. Heming Li is an oncology clinician-scientist whose research has generated 1,045 citations across 37 scientific documents with an h-index of 17, reflecting a sustained impact on translational cancer science. His work centers on liquid biopsy innovations, particularly circulating tumor cells (CTCs), tumor invasion and metastasis, and immunotherapy biomarkers in lung, gastric, and hepatobiliary cancers. Dr. Li is recognized for pioneering one of China’s earliest and most sensitive cell-surface vimentin (CSV)–based CTC detection platforms, integrating negative and positive enrichment to enhance diagnostic accuracy, reduce costs, and enable real-time monitoring of tumor evolution. His research spans EMT regulation, immune escape, metabolic reprogramming, and multi-omics characterization of metastatic pathways, leading to first-author and corresponding-author publications in high-impact journals such as The Lancet, Journal of Hematology & Oncology, Journal of Experimental & Clinical Cancer Research, Molecular Cancer, Cancer Letters, and Cell Death & Disease. He has elucidated mechanisms including IGF-IR signaling, KDM4A/STAT3-driven tumor progression, ICAM-1-mediated microenvironmental adaptation, and PD-L1 expression on CSV⁺ CTCs as a prognostic marker in gastric cancer. His recent studies have also advanced understanding of FGL1 as an immune checkpoint target and the biological significance of TROP2 in cancer therapeutics. As principal investigator, he has secured major national and provincial funding, including NSFC General and Young Programs, to study CTC-based biomarkers, immunotherapy prediction models, and metastasis-driving pathways. Through sustained contributions across liquid biopsy technology, molecular oncology, and clinically actionable biomarker development, Dr. Li has established a leading research profile shaping the future of precision cancer care.

Profile: Scopus  

Featured Publications

Muhammad Zulfiqar | Biomedical Instrumentation | Best Researcher Award

Published on by Medical Lab Scientist

Mr. Muhammad Zulfiqar | Biomedical Instrumentation | Best Researcher Award

PhD Scholar at National University of Science and Technology NUST, Islamabad, Pakistan

Engr. Muhammad Zulfiqar is a passionate and driven mechanical engineer currently pursuing a Ph.D. in Mechanical Engineering at the National University of Sciences and Technology (NUST), Islamabad. With a strong academic foundation, multiple published works, and extensive teaching experience, he has demonstrated consistent excellence in both technical and pedagogical domains. His career reflects a steadfast commitment to research, education, and innovation, positioning him as a rising contributor in Pakistan’s engineering landscape. A dynamic individual, he excels in both collaborative and independent environments, effectively combining academic rigor with practical applications across renewable energy, microfluidics, and sustainable development sectors.

profile

orcid

Education

Muhammad Zulfiqar has pursued a rigorous academic path beginning with a Bachelor of Science in Mechanical Engineering from HITEC University Taxila, followed by a Master’s degree in Mechanical Engineering from NUST, Islamabad. Currently, he is enrolled in the Ph.D. program at NUST, maintaining a perfect 4.0 CGPA. His formal education is supplemented by his early scholastic achievements, consistently earning first division distinctions in intermediate and matriculation levels. Throughout his academic journey, he has shown a continuous thirst for knowledge and an ability to engage deeply with complex engineering concepts.

Experience

Zulfiqar’s academic career spans several respected institutions across Pakistan. He currently serves as a lecturer at Capital University of Science and Technology (CUST), Islamabad, a position he has held since March 2020. Prior to this, he contributed as a lecturer at the University of Lahore, University of Management and Technology (UMT) Sialkot, and the University of Engineering and Technology (UET) Taxila. His earlier engagements include roles as a lab demonstrator and teaching assistant at NUST, where he provided course support in fluid mechanics and undertook responsibilities in grading and assessments. In addition to academia, he briefly worked as a mechanical engineer in the Provincial Maintenance Machinery Division in Rawalpindi, further diversifying his professional exposure.

Research Interest

Muhammad Zulfiqar’s primary research interests lie at the intersection of microfluidics, renewable energy, and heat transfer. His current doctoral research delves into the simulation and experimental validation of microfluidic devices for biological applications. He is equally invested in the advancement of sustainable energy technologies, particularly in the context of Pakistan’s evolving energy infrastructure. His passion for microfluidics bridges theoretical modeling with experimental applications, offering promising insights for innovations in biomedical and environmental engineering.

Awards

Muhammad Zulfiqar’s dedication and talent have been recognized in various academic and extracurricular platforms. He secured first place in an essay writing competition at UET Taxila and second position in a bridge structure competition at NUST Islamabad. Notably, he achieved an outstanding 98% student feedback score in his course evaluations and scored in the 95.08 percentile in the GAT Subject Test for Mechanical Engineering conducted in 2019. These accolades reflect both his academic proficiency and his ability to inspire and engage students effectively.

Publications

Muhammad Zulfiqar has contributed extensively to scholarly research, publishing multiple articles in reputable journals and conference proceedings. Selected publications include:

“Simulation and Experimental Validation of Microfluidic Device for Cell Focusing and Sorting Based on Inertial Microfluidics Technique”, Materials Proceedings MDPI, 2025 – cited in studies on microfluidic bio-sorting.

“Experimental Study on Multi-Cell Counting Using an Inertial Microfluidic Device”, Journal of Applied Science MDPI, 2025 – influencing biomedical engineering methods.

“Experimental Investigation of Particle Sorting in Y-Channels with Variable Bifurcation Angles for Microfluidic Applications”, Journal of Applied Science and Engineering, 2024 – referenced in micro-scale fluid dynamics research.

“Pakistan’s Transport Sector Modeling Using AIM/Enduse”, Engineering Proceedings MDPI, 2024 – cited in policy-oriented modeling.

“Women Empowerment through Clean Energy Transition in Pakistan”, Engineering Proceedings MDPI, 2024 – referenced in gender-energy policy studies.

“Pakistan’s Electric Vehicles Market: Challenges and Opportunities”, Engineering Proceedings MDPI, 2024 – cited in environmental technology papers.

“Accelerating Green Energy Transition Under CPEC 2.0”, Engineering Proceedings MDPI, 2024 – supporting literature in regional energy policy discourse.

Conclusion

Engr. Muhammad Zulfiqar exemplifies the qualities of a top-tier researcher—intellectually rigorous, prolific in publication, interdisciplinary in approach, and dedicated to educational excellence. His contributions to microfluidics and renewable energy, combined with impactful academic service and leadership, make him a highly suitable candidate for the Best Researcher Award. Recognizing his work would not only honor individual excellence but also highlight the importance of research-driven development in engineering and sustainability.

 

Wenqing Li | Immunology & Serology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. Wenqing Li | Immunology & Serology | Best Researcher Award 

Professor at Nantong University School of Medicine, China

Professor Wenqing Li is a distinguished scientist in the field of biomedical science, currently serving as a professor at the School of Medicine, Nantong University. He holds a B.S. in Biological Sciences from Anhui Normal University (2009) and a Ph.D. in Cell Biology from the University of Science and Technology of China (2014). His postdoctoral training was conducted at The Pennsylvania State University (2014–2016), followed by a research position at The Ohio State University (2016–2020). Since 2020, he has led an innovative research program at Nantong University, contributing significantly to the fields of nanomedicine, cancer immunotherapy, and male reproductive health.

profile

scopus

Education

Dr. Li’s academic journey is rooted in top-tier Chinese and American institutions. He began with a Bachelor’s degree in Biological Sciences at Anhui Normal University, developing a strong foundation in molecular biology. His passion for advanced cellular mechanisms led him to pursue a Ph.D. in Cell Biology at the prestigious University of Science and Technology of China, where he cultivated expertise in nanobiotechnology. Further enhancing his academic experience, he undertook rigorous postdoctoral research at The Pennsylvania State University, followed by a role as assistant researcher at The Ohio State University. These global experiences shaped his multidisciplinary approach to research in biomedicine.

Experience

Dr. Li’s professional experience spans academia and international research environments. His early postdoctoral work at Penn State focused on nanomaterials and bio-conjugates. At Ohio State, he contributed to translational nanomedicine, developing innovative drug delivery systems. His current role as professor at Nantong University involves supervising research in lipid nanoparticle-based therapeutics, immunotherapy, and reproductive biology. A recognized research leader, he is also a key member of the Jiangsu Provincial Outstanding Scientific and Technological Innovation Team for Male Reproductive Health and has successfully secured and led major grants from the National Natural Science Foundation of China.

Research Interest

Professor Li’s research interests lie at the intersection of nanotechnology, molecular biology, and immunotherapy. His current work centers on the development of lipid nanoparticles for mRNA delivery and cancer immunotherapy, including platforms co-delivering STING agonists and mRNA to synergize antitumor responses. He also investigates lipid nanoparticle applications in restoring spermatogenesis in infertile males and treats Non-Obstructive Azoospermia (NOA). His broad interests also include nanotoxicology and male contraceptive development using functionalized nanomaterials. His translational research has bridged fundamental science with therapeutic innovations.

Award

Professor Li was honored with the Jiangsu Distinguished Professor Award in 2020 in recognition of his contributions to biomedical science and innovation. He was also the recipient of funding from the National Natural Science Foundation of China (Youth Program) between 2016 and 2018 for his work on the reproductive toxicity of gold nanoparticles. His innovative research and leadership in translational nanomedicine have garnered national attention, positioning him as a strong contender for the Best Researcher Award.

Publication

Among his numerous high-impact publications, seven notable articles include:

“Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis” published in Nature Nanotechnology (2020), cited 226 times.

“Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing” published in Science Advances (2020), cited 144 times.

“Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo” in Advanced Materials (2020), cited 106 times.

“Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy” in Nature Communications (2021), cited 82 times.

“Ratiometric fluorescent probes for capturing endogenous hypochlorous acid in the lungs of mice” in Chemical Science (2018), cited 99 times.

“Long-term storage of lipid-like nanoparticles for mRNA delivery” in Bioactive Materials (2020), cited 183 times.

“Amplifying the Antitumor Effect of STING Agonist MSA-2 by Phospholipid Nanoparticles Delivering STING mRNA and Copper-Modified MSA-2 Combination” in ACS Applied Materials & Interfaces (2025), early-stage with growing recognition.
These publications have significantly influenced nanomedicine, genome editing, and therapeutic delivery systems.

Conclusion

In conclusion, Dr. Wenqing Li exemplifies the qualities of an outstanding researcher. His academic rigor, innovation in lipid-based nanotechnology, impactful publications, and translational focus collectively position him as a leading figure in biomedical science. His contributions not only push the boundaries of current knowledge but also pave the way for novel therapeutic approaches. Therefore, it is with strong confidence that Dr. Wenqing Li is recommended as a highly deserving recipient of the Best Researcher Award.